IgG1 Antibody - #DF8170
| Product: | IgG1 Antibody |
| Catalog: | DF8170 |
| Description: | Rabbit polyclonal antibody to IgG1 |
| Application: | WB IF/ICC |
| Reactivity: | Human |
| Mol.Wt.: | 36kDa; 36kD(Calculated). |
| Uniprot: | P01857 |
| RRID: | AB_2841490 |
Product Info
*The optimal dilutions should be determined by the end user.
*Tips:
WB: For western blot detection of denatured protein samples. IHC: For immunohistochemical detection of paraffin sections (IHC-p) or frozen sections (IHC-f) of tissue samples. IF/ICC: For immunofluorescence detection of cell samples. ELISA(peptide): For ELISA detection of antigenic peptide.
Cite Format: Affinity Biosciences Cat# DF8170, RRID:AB_2841490.
Fold/Unfold
Ig gamma 1 chain C region; IgG heavy chain locus; IGHG1; Immunoglobulin Gm1; Immunoglobulin heavy constant gamma 1 (G1m marker);
Immunogens
- P01857 IGHG1_HUMAN:
- Protein BLAST With
- NCBI/
- ExPASy/
- Uniprot
ASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSRDELTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK
PTMs - P01857 As Substrate
| Site | PTM Type | Enzyme | Source |
|---|---|---|---|
| S7 | Phosphorylation | Uniprot | |
| S17 | Phosphorylation | Uniprot | |
| T18 | Phosphorylation | Uniprot | |
| S19 | Phosphorylation | Uniprot | |
| T22 | Phosphorylation | Uniprot | |
| C27 | S-Nitrosylation | Uniprot | |
| T133 | Phosphorylation | Uniprot | |
| S137 | Phosphorylation | Uniprot | |
| C144 | S-Nitrosylation | Uniprot | |
| N180 | N-Glycosylation | Uniprot | |
| S247 | Phosphorylation | Uniprot | |
| T249 | Phosphorylation | Uniprot | |
| S323 | Phosphorylation | Uniprot | |
| S325 | Phosphorylation | Uniprot | |
| S327 | Phosphorylation | Uniprot |
Research Backgrounds
Constant region of immunoglobulin heavy chains. Immunoglobulins, also known as antibodies, are membrane-bound or secreted glycoproteins produced by B lymphocytes. In the recognition phase of humoral immunity, the membrane-bound immunoglobulins serve as receptors which, upon binding of a specific antigen, trigger the clonal expansion and differentiation of B lymphocytes into immunoglobulins-secreting plasma cells. Secreted immunoglobulins mediate the effector phase of humoral immunity, which results in the elimination of bound antigens. The antigen binding site is formed by the variable domain of one heavy chain, together with that of its associated light chain. Thus, each immunoglobulin has two antigen binding sites with remarkable affinity for a particular antigen. The variable domains are assembled by a process called V-(D)-J rearrangement and can then be subjected to somatic hypermutations which, after exposure to antigen and selection, allow affinity maturation for a particular antigen.
Secreted. Cell membrane.
Immunoglobulins are composed of two identical heavy chains and two identical light chains; disulfide-linked.
Restrictive clause
Affinity Biosciences tests all products strictly. Citations are provided as a resource for additional applications that have not been validated by Affinity Biosciences. Please choose the appropriate format for each application and consult Materials and Methods sections for additional details about the use of any product in these publications.
For Research Use Only.
Not for use in diagnostic or therapeutic procedures. Not for resale. Not for distribution without written consent. Affinity Biosciences will not be held responsible for patent infringement or other violations that may occur with the use of our products. Affinity Biosciences, Affinity Biosciences Logo and all other trademarks are the property of Affinity Biosciences LTD.